Novanta Inc. Common Stock
NOVT CA67000B1040
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
50% | -22% | 25% | -7% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Buckley Robert CFO |
170.16 USD |
1,617 Sold |
275,149 USD |
04/12/2024 | 04/12/2024 |
Buckley Robert CFO |
169.92 USD |
427 Sold |
72,556 USD |
02/12/2024 | 02/12/2024 |
Buckley Robert CFO |
165.87 USD |
172 Sold |
28,530 USD |
02/12/2024 | 02/12/2024 |
Buckley Robert CFO |
166.84 USD |
386 Sold |
64,400 USD |
02/12/2024 | 02/12/2024 |
Glastra Matthijs CEO |
169.28 USD |
944 Sold |
159,800 USD |
02/12/2024 | 02/12/2024 |
Buckley Robert CFO |
169.02 USD |
480 Sold |
81,130 USD |
02/12/2024 | 02/12/2024 |
Buckley Robert CFO |
167.95 USD |
576 Sold |
96,739 USD |
02/12/2024 | 02/12/2024 |
Glastra Matthijs CEO |
166.27 USD |
207 Sold |
34,418 USD |
02/12/2024 | 02/12/2024 |
Glastra Matthijs CEO |
167.29 USD |
174 Sold |
29,108 USD |
02/12/2024 | 02/12/2024 |
Glastra Matthijs CEO |
168.43 USD |
675 Sold |
113,690 USD |
02/12/2024 | 02/12/2024 |